Phone Whasapp

VEEDA CLINICAL RESEARCH LIMITED Unlisted Share Price & Company Details

VEEDA CLINICAL RESEARCH LIMITED

COMPANY NAME VEEDA CLINICAL RESEARCH LIMITED
NATURE OF BUSINESS LIFE SCIENCES & HEALTHCARE (CRO)
ISIN NO INE01HQ01026
FACE VALUE Rs.2/-
PROMOTERS BASIL PRIVATE LIMITED
COMPANY WEBSITE veedalifesciences.com
YEAR OF ESTABLISHMENT 2004
REGISTERED ADDRESS SHIVALIK PLAZA-A, 2nd FLOOR, OPP. AHMEDABAD MANAGEMENT ASSOCIATION, AMBAWADI, AHMEDABAD, GUJARAT - 380015.

BOARD OF DIRECTORS

Mr. NITIN DESHMUKH (CHAIRMAN & INDEPENDENT DIRECTOR )
Mr. BINOY GARDI (FOUNDER, MD & GROUP CEO)
Mr. APURVA SHAH ( CO-FOUNDER & NON-EXECUTIVE DIRECTOR)
Mr. JEANNE HECHT ( INDEPENDENT DIRECTOR)


Veeda Clinical Research Limited is one of India’s leading independent full-service Contract Research Organizations (CRO). Established in 2004, the company provides a comprehensive range of clinical research services to global pharmaceutical and biopharmaceutical companies. Veeda specializes in early clinical development, focusing on high-quality data and regulatory compliance with global standards such as the USFDA, EMA, and MHRA.

The company operates through a network of advanced facilities and subsidiaries (such as Bioneeds for preclinical services and Heads for European operations), positioning itself as a one-stop development partner from discovery to market launch.

Veeda has significantly scaled its operational footprint in India to handle high-volume clinical research. Veeda have 3 major clinical units (2 in Ahmedabad, 1 in Mehsana), Combined capacity of 588 beds, making it one of the largest clinical facility providers in India. Have Access to a network of over 280+ clinical sites across India for patient-based trials and robust database of 60+ investigators and over 10,000+ enrolled patients across various therapeutic studies.


Products / Services of Company

  • • Bioavailability & Bioequivalence (BA/BE) Studies: Full-service studies for generic drug development conducted in state-of-the-art clinical units
  • • Early Phase Clinical Pharmacology: Expertise in Phase I (First-in-Human) and Phase II trials.
  • • Preclinical Research: Toxicology, pharmacology, and safety assessment services through its subsidiary, Bioneeds
  • • Biopharmaceutical Services: Specialized services for biosimilars and large molecules, including clinical bioanalysis and immunogenicity testing.
  • • Late Phase Clinical Trials: Managing Phase III and Phase IV trials across multiple therapeutic areas globally.
  • • Data Science & Biometrics: Clinical data management, biostatistics, and medical writing services.

ANNUAL REPORT

NEWS